Stocks and Investing
Stocks and Investing
Fri, January 20, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, January 19, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Christopher Raymond Maintained (AMGN) at Buy with Decreased Target to $293 on, Jan 19th, 2023
Christopher Raymond of Piper Sandler, Maintained "Amgen Inc." (AMGN) at Buy with Decreased Target from $299 to $293 on, Jan 19th, 2023.
Christopher has made no other calls on AMGN in the last 4 months.
There are 7 other peers that have a rating on AMGN. Out of the 7 peers that are also analyzing AMGN, 3 agree with Christopher's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Mohit Bansal of "Wells Fargo" Maintained at Hold with Increased Target to $285 on, Tuesday, January 3rd, 2023
- David Risinger of "SVB Leerink" Maintained at Hold with Increased Target to $282 on, Thursday, December 22nd, 2022
- Gregory Renza of "RBC Capital" Maintained at Hold with Increased Target to $240 on, Friday, November 4th, 2022
These are the ratings of the 4 analyists that currently disagree with Christopher
- Carter Gould of "Barclays" Maintained at Sell with Increased Target to $240 on, Wednesday, January 18th, 2023
- Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $310 on, Tuesday, December 6th, 2022
- Trung Huynh of "Credit Suisse" Initiated at Sell and Held Target at $240 on, Friday, November 18th, 2022
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $282 on, Friday, November 4th, 2022
Contributing Sources